4//SEC Filing
Daly Richard J 4
Accession 0001161697-25-000300
CIK 0001369568other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 5:00 PM ET
Size
8.9 KB
Accession
0001161697-25-000300
Insider Transaction Report
Form 4
Daly Richard J
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2025-08-26$2.24/sh+50,000$112,000→ 249,764 total - Exercise/Conversion
Options to purchase common stock
2025-08-26−50,000→ 2,184,753 totalExercise: $2.24Exp: 2025-12-19→ Common Stock (50,000 underlying) - Sale
Common stock, par value $0.001 per share
2025-08-26$20.62/sh−22,970$473,641→ 226,794 total
Footnotes (2)
- [F1]Shares were sold on the open market to fund the exercise price and tax withholding due from Mr. Daly on the exercise of the 50,000 stock options reported on Table II.
- [F2]Derivative securities vested in three annual tranches beginning on December 19, 2019.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001635393
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 5:00 PM ET
- Size
- 8.9 KB